Bio-Link is a drug development company founded in 2001 and headquartered in Shanghai, China. It specializes in providing bioprocessing solutions for the life science industry, including the development and manufacturing of key process equipment and consumables. Bio-Link's offerings include technologies for vaccines, antibody drugs, cell therapy, gene therapy, and various biologics. The company focuses on upstream cell culture, disposable dispensing reservoirs, and downstream processes such as chromatography and ultrafiltration. By delivering innovative products and services, Bio-Link aims to enhance the efficiency, safety, and competitiveness of the biopharmaceutical supply chain. Additionally, the company explores wearable technology solutions for elderly care, further diversifying its portfolio.
Snapdragon Chemistry
Acquisition in 2022
Snapdragon Chemistry, Inc. specializes in continuous flow chemistry solutions tailored for the discovery and production of active pharmaceutical ingredients, intermediates, and materials. The company provides a range of services, including process development, reactor design and construction, portfolio optimization, and GMP manufacturing. By addressing the chemistry challenges faced by pharmaceutical, chemical, animal care, and material science sectors, Snapdragon Chemistry enables clients to create scalable synthetic processes. Founded in 2014 and based in Waltham, Massachusetts, the company was previously known as Firefly Chemistry, Inc. before rebranding in April 2015.
LaNova Medicines
Series A in 2021
LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.